GLP-1 Providers With First Month Discount: What You Pay Today, and What Hits Your Card Next

Published by Weight Loss Provider Guide, an independent comparison resource for GLP-1 telehealth providers
Last verified: August 11, 2026 · 16 provider and manufacturer routes audited · 4 primary paths recommended

Disclosure: Some links on this page earn us a commission. It never changes your price, and it never changes what we found. Three routes in our table pay us nothing. Two programs that could pay us are listed here with no signup link because of published FDA warning letters, and we explain exactly why. — Our advertising disclosure

The short answer

Most GLP-1 providers with first month discount offers are not discounting the same thing. Some cut the membership fee. Some cut the first medicine order. Some show a monthly average for a bundle that is charged all at once.

Of the 16 routes we audited on August 11, 2026, the lowest verified medicine-included amount due today is Noom at $49 for four weeks of low-dose compounded semaglutide. The first renewal is $537 for twelve weeks, before tax. The lowest verified flat monthly cash price is Embody at $79 a month for compounded semaglutide, with the same price for the same medicine and plan. Three monthly payments total $237.

If you want an FDA-approved medicine for weight management, the lowest verified self-pay medicine price starts at $149 for the lowest dose of the Wegovy pill or Foundayo. A telehealth membership may be added. On Ro's true month-to-month route, the lowest-dose pill path is $188 at the first charge—$39 membership plus $149 medicine—and $298 at the next charge if the medicine stays at $149, because the membership rises to $149.

And if commercial insurance or the Medicare GLP-1 Bridge might cover you, check that before paying cash. A covered route may cost less, but coverage, copays, prior authorization and visit fees still vary.

Here's the part almost nobody puts in one place: the discount is not the deal. The next automatic charge is the deal. We list what leaves your card now, what can leave it next, what that payment buys, and the safest cancel-by rule we could verify.

The 60-second verdict

Before you scroll: the one number to look for

Every program on this page has two numbers.

The first number is what you pay today. That's the one in the ad.

The second number is what your card gets charged next. That's the one that decides whether you can keep going.

There is also a third question that matters: how many weeks does the second payment buy? A $537 twelve-week charge is not the same product as a $179 four-week charge, even though the four-week average is the same.

Most comparison pages publish the first number. We publish the cash charge, the billing period, the renewal rule and the part of the bill the ad leaves out. That's the whole page. Let's go.

GLP-1 providers with first month discount: which deals are live?

Answer: Twelve of the 16 provider and manufacturer routes in this audit clearly publish an intro discount, new-customer offer or starter-dose price. Several others publish a low flat price, a prepaid average or only a starting price. Those are not the same thing.

Here's the quick list before the deep table.

Medicine or medicine-included program discounted at the start: Noom ($49 semaglutide or $79 tirzepatide for the first four weeks) · Direct Meds ($199 first month, then $399) · Enhance.MD ($50 off a one-month plan or $100 off a three-plus-month plan) · NovoCare's Wegovy pen offer ($199 for the first two starter-dose fills) · Helimeds EasyStart ($99 per month as a three-month average, paid upfront)

Membership or care fee discounted at the start: Ro ($39 first month) · Hims and Hers ($39 first month) · Eden ($39 first month) · Mochi ($39 first month where offered) · Alloy ($50 off the first month of care) · WeightWatchers Med+ ($25 for the first two months) · PlushCare (first 30 days of membership free)

A starting price that is not a fully verified first-month-to-refill sequence: MEDVi advertises injections starting at $179, but its current public page does not publish one fixed refill price. We do not print the old $299 refill claim as a current fact.

No intro price to expire: Embody publishes $79 monthly compounded semaglutide and $129 monthly compounded tirzepatide under its current plan. Yucca publishes monthly prices and lower six-month averages. Neither is a one-month promo.

Manufacturer cash-pay routes, not a telehealth company's private discount: NovoCare for Wegovy and LillyDirect for Zepbound or Foundayo. A telehealth site may help write or route the prescription, but the medicine price comes from the manufacturer program.

That last group matters more than people realize. When several websites show the same Wegovy or Zepbound price, the price is often coming from Novo Nordisk or Eli Lilly. The useful way to choose the telehealth company is then the care fee, refund rule, insurance help and cancellation setup—not who repeats the manufacturer price the loudest.

What you pay today vs. what you pay next: the full audit

Answer: The lowest advertised membership-only payment in this audit is $25. The lowest verified medicine-included payment is $49. The largest published next automatic charge is Noom's $597 twelve-week tirzepatide renewal. The largest upfront bundle shown here is Yucca's $1,350 six-month tirzepatide plan.

This is our GLP-1 Intro Price Reality Index. It does not pretend every row is the same medical product. It shows the cash event: what leaves your card, what happens next, and what the next payment buys.

The main table

How to read the table: “Next automatic charge” means the next charge we could verify from the published plan. It does not predict what a clinician will prescribe. Taxes, labs, needles, insurance cost-sharing and state availability can change the total. A dash or “not publicly fixed” is a gap, not permission to guess.

What we actually verified

Read directly on official pages on August 11, 2026: Embody, Noom, Ro, Hims/Hers, Yucca, MEDVi's starting price and cancellation policy, Direct Meds, Eden, Enhance.MD, Alloy, Helimeds, WeightWatchers, PlushCare, Mochi, NovoCare, LillyDirect, FDA warning letters and Medicare Bridge rules.

Independently calculated by us: combined membership-plus-medicine totals; coupon subtraction; first-three-payment totals; four-week equivalents; and the cash difference between a displayed monthly average and the amount charged upfront.

Still unknowable before intake or checkout: whether a clinician will prescribe, your exact dose, a state-specific restriction, your insurance payment and any checkout-only fee or tax.

Provider-stated price vs. verified transaction

A note on Noom's numbers. Do not compare $49 with $537 as if they buy the same amount of time. One buys four weeks. The other buys twelve. The four-week rate rises from $49 to $179, but the cash hit rises by $488 at the renewal.

→ Before you pick anything, run your own numbers. Add the amount due now, the next automatic charge, and one more charge at the same cadence. If the next charge covers twelve weeks, do not count it as one month. The first-90-day table below does the math for every route we could verify.

The five kinds of “first month discount”

Answer: A GLP-1 first-month discount can cut the medicine, the membership, the clinician visit, a prepaid bundle or nothing at all. Comparing a $39 membership with a $49 medicine-included plan is comparing two different products.

Type 1 — The medicine is included, and the first supply is cheaper

Who does this: Noom and Direct Meds. Enhance.MD also gives a first-order coupon, but its homepage headline and its one-month cash path are not the same number.

One price covers the medicine and some level of clinical care. This is the easiest kind of offer to understand only when the refill amount and billing period sit next to it.

Type 2 — The discount is on the membership, not the medicine

Who does this: Ro, Hims, Hers, Eden, Mochi, Alloy and WeightWatchers.

“$39 to start” means the platform costs $39 this month. The medicine may be a second charge. With Ro's lowest-dose Wegovy pill route, $39 + $149 = $188 on the first charge, not $39.

This is not automatically a trick. It is a different bill. But if you budgeted $39 and needed $188, that's a bad first day.

Type 3 — The clinician membership is free, but the visit is not

Who does this: PlushCare.

Thirty free days of membership sounds like a free month of treatment. It isn't. The initial uninsured visit is $129. Medicine and lab costs are separate, and PlushCare says labs are often required.

Type 4 — It is a prepaid bundle wearing a monthly price tag

Who does this: Helimeds and many three-, six- or twelve-month plans.

Helimeds advertises $99 a month. The displayed plan works out to $297 paid once for twelve weeks. It is not an auto-renewing monthly subscription.

Ro's “as low as $74/month” means $888 paid upfront for twelve months. Enhance.MD's lowest monthly average is attached to a 48-week billing option. Yucca's $125 semaglutide figure means $750 for six months.

There is nothing wrong with prepaying. There is something wrong with budgeting for the average instead of the card charge.

Type 5 — No intro discount, just a lower current price

Who does this: Embody's current plan.

Nothing expires after month one. Embody's terms publish $79 monthly compounded semaglutide and $129 monthly compounded tirzepatide, with no price increase while you stay on the same medicine and plan. Prices can still change in the future under a provider's terms, so confirm at checkout.

This is the category people searching for a discount often miss, and it produced the lowest three-monthly-payment total in this audit.

The Billing Clarity Score

We scored public pages on five yes-or-no questions. Every point is something you can check before entering a card. This is a billing-transparency score. It is not a medical, safety or care-quality score.

1. Is the actual amount charged today clear, rather than only a monthly average?
2. Is the next automatic charge and billing period clear?
3. Is it clear whether medicine is included?
4. Is the cancellation deadline or auto-renewal rule easy to find?
5. Is it clear whether the medicine price changes with dose?

Yucca is the interesting one. Its public billing detail is incomplete, yet its charging rule is unusually fair: an authorization hold first, then a completed charge only if prescribed. Those two facts can be true at once. A score is a starting point, not a verdict.

Why can the second GLP-1 charge jump?

Answer: The jump usually comes from one of three things: the intro membership ends, the next order covers more weeks, or the medicine price rises with dose. Sometimes two happen in the same charge.

This is the single most useful thing on this page, so let's slow down.

Many FDA-approved GLP-1 medicines start at a lower dose and step up under a clinician's direction. The schedule depends on the drug, your response and the prescribing information. A price tied to dose can rise when the dose rises.

But dose is not the only cause:

• Noom's low-dose semaglutide moves from a four-week $49 supply to a twelve-week $537 renewal. The refill is bigger because it buys three times as many weeks, and the four-week rate also rises to $179.
• Ro, Hims and Hers move from a $39 first-month membership to $149 month to month. Medicine is a second charge.
• Ro and NovoCare's Wegovy pen offer is $199 for the 0.25 mg and 0.5 mg starter fills. The published 1 mg price is $349.
• Ro's Wegovy pill is $149 at 1.5 mg, $149 promotional pricing at 4 mg for qualifying signups through August 31, 2026, and $299 at 9 mg and 25 mg.
• Foundayo starts at $149 for 0.8 mg, then $199 at 2.5 mg and $299 at several higher doses under the current manufacturer pricing.
• Zepbound KwikPen starts at $299 for 2.5 mg, rises to $399 at 5 mg and can be $449 at higher doses under the refill offer terms.

The numbers were published. They were just spread across the membership card, medicine card, dose table and footnotes.

Five price behaviors, in plain English

If you may stay on treatment for a year, compare the full-year cash flow, not the first coupon. A one-time $100 discount saves $100 once. A $100 lower ongoing four-week cost can change the year by about $1,300.

The 28-day trap

A “month” can mean a calendar month, 30 days or four weeks.

Four-week billing creates 13 payment periods in 364 days, not 12. At $299 per four-week fill, 13 fills total $3,887. Multiplying $299 by 12 gives $3,588—a $299 gap.

Do not assume a provider bills every 28 days unless its page or checkout says so. Check for the exact words “every four weeks,” “28 days,” “monthly” or “billed every 48 weeks.”

You cannot budget around a price that moves without a rule. Embody currently publishes one amount for each monthly compounded medicine and says the price does not rise while you stay on that medicine and plan.

Read our document-based Embody review →

Embody's medicines on this plan are compounded and are not FDA-approved. Read the compounding section before choosing.

What's actually cheapest over the first 90 days?

Answer: Embody's compounded semaglutide is the lowest complete three-monthly-payment route we could calculate at $237. Helimeds is $297 for one prepaid twelve-week supply with no auto-renewal. The order changes fast once we add the next charge.

There is no perfect apples-to-apples “90-day” table because some companies bill monthly, some every four weeks, some for twelve weeks and some upfront. We use the closest honest cash-flow measure:

• Monthly or four-week plans: first three scheduled payments.
• Noom: the initial four-week payment plus its first twelve-week renewal, which covers sixteen weeks.
• Helimeds: the one twelve-week EasyStart payment.
• Manufacturer routes: medicine only, before any care fee.
• Membership-only routes: shown separately instead of pretending medicine costs $0.

Sorted by the amount due at the start

1. WeightWatchers Med+ — $25 (membership only)
2. Ro / Hims / Hers / Eden / Mochi — $39 (membership or care fee only)
3. Noom compounded semaglutide — $49 (medicine included, before tax)
4. Embody compounded semaglutide — $79
5. Mochi compounded semaglutide minimum — $99 total
6. Alloy minimum — $119 total
7. Yucca compounded semaglutide — $146 if prescribed
8. MEDVi compounded injection — from $179
9. Direct Meds compounded tirzepatide — $199

Sorted by the first three payments or closest published cash window

Not ranked because the full next cost is missing: MEDVi.
Not ranked because medicine is excluded: WeightWatchers and PlushCare.
Not treated as equivalent: compounded products and FDA-approved medicines.

Read one number twice: Noom looks $30 cheaper than Embody on day one. By Noom's first renewal, you have paid $586 for sixteen weeks. Four Embody monthly payments total $316. The periods are not identical, but the cash-flow gap over roughly the same four-month window is $270. Nobody advertises that number.

One honest caveat: these rows do not sell the same product. The lowest rows are mostly compounded medicines, which are not FDA-approved. Wegovy, Zepbound and Foundayo are FDA-approved for weight management. This table compares cash flow, not medical equivalence.

Does the first month price include the medicine?

Answer: In our 16-route family count, nine headline prices include the medicine or are the medicine price itself. Seven exclude medicine. When the medicine is separate, the number in the headline can be less than half of the first total payment.

A GLP-1 bill can have several parts. Most ads put one part in the largest type.

The word included does not mean guaranteed. A clinician must decide whether a prescription is appropriate.

The six questions to answer before you enter a card

Copy these. Ask them at checkout or in the chat window.

1. What exact dollar amount will be charged today?
2. Does that amount include the medicine?
3. What is the next charge, in dollars?
4. How many days or weeks does that next charge cover?
5. Does the price change when my dose changes?
6. What date must I cancel by to avoid it?

Add one more for prepaid plans: Is this a monthly charge or a monthly average?

If a program cannot answer all seven before you pay, that's the answer.

What if I pay and then don't qualify?

Answer: Programs handle this in very different ways. Yucca says it places a card authorization hold and completes the charge only if a provider prescribes. Ro says the $39 first-month membership is refunded if you are not eligible for a GLP-1. Embody charges at checkout before the final clinician decision, and its public refund pages conflict.

This is the fear almost nobody writes about, and it matters more than a coupon.

Here's the honest problem with our lowest flat-price pick

Embody charges your card before an OpenLoop Health clinician finishes deciding whether you qualify.

That is not our guess. Embody's own disclosure says the clinician review happens after checkout. Its Terms say the initial charge occurs at checkout and consultation fees are not refundable, while medicine that was not dispensed may qualify for a refund. Its separate refund page says a customer who is medically disqualified receives a full refund.

Those statements do not fit together cleanly.

Before paying Embody, ask support this exact question and save the answer: “If the clinician does not prescribe, will every dollar of today's charge be refunded, including the consultation fee?”

Two cleaner doors when approval risk worries you:

• Ro publishes a plain promise that the $39 first-month membership is refunded if you are not eligible.
• Yucca Health says it places an authorization hold and charges only if prescribed.

Do not try to decide your own eligibility from a list on a comparison page. A licensed clinician must review your health history, medicines and the product's prescribing information.

Who charges when

Not sure you will qualify? Start where the money rule is written in one sentence. Ro publishes the $39 eligibility refund, and Yucca publishes the authorization-hold rule.

Can I cancel before the second charge—and by when?

Answer: Canceling and getting a refund are two different things. Most programs let you stop a future renewal. Almost none promise a refund after a medicine has shipped or a prepaid term has started. The safest deadline is the strictest written deadline you can find, not the softest sentence in an FAQ.

Cancel does not mean refund

Three words that cost people real money:

• Cancel — stops a future renewal if the request arrives before the deadline.
• Refund — returns money already taken. Prescription medicine is often nonrefundable after it ships.
• Pause — delays a future order. A pause may not erase a membership fee or preserve an intro rate.

The cancel-by register

The five-minute routine that protects you

Do this the day you sign up.

1. Screenshot the checkout total before confirming. If it does not match the page that brought you there, stop.
2. Write the billing period beside the price: monthly, every four weeks, twelve weeks or prepaid term.
3. Put the cancel-by date in your phone, not only the renewal date. If the rule is five days, set your reminder seven days early.
4. Save the confirmation email and terms page. Terms can change.
5. If you cancel, get a written confirmation. Save the email or chat transcript.

Learn the name on your bank statement too. Embody's Terms say charges may appear as Modern Metabolic Medicine, Inc., not “Embody.”

One thing almost nobody mentions

Embody's Terms include binding arbitration and a class-action waiver. They also give you a 30-day opt-out. The Terms say the notice must include your name, address, JoinEm account details and a clear statement that you are opting out, sent within 30 days to the listed mailing or email address.

Many telehealth terms have dispute clauses. Read the version you accept. This page does not tell you whether opting out is right for you; it tells you the deadline exists.

→ Your cancel-by formula: next billing date minus the provider's notice period. Put the result in your calendar now. No email gate. No fake countdown.

Which “deals” are not really one-month discounts?

Answer: Three patterns show up again and again: a prepaid bundle shown as a monthly rate, an annual plan shown as a monthly rate and an old promotion still repeated after the company retired it. In each case, the number in large type is not the current one-month cash event.

The prepaid bundle in monthly clothing

Helimeds advertises EasyStart at $99 a month. The official footnote says the twelve-week plan is paid upfront, is not a subscription and has no automatic billing. The displayed math is $297 once. An optional later four-week order is $239.

There is nothing wrong with prepaying. There is something wrong with budgeting $99 and reaching a $297 checkout.

The tell: “paid upfront,” “billed every 12 weeks,” “billed every 48 weeks” or “as low as.”

The annual plan in monthly clothing

Ro's “as low as $74/month” is a real monthly average. It requires a twelve-month prepaid membership: $888 upfront. Ro states this on the pricing page. The month-to-month membership is $149 after the $39 first month.

Enhance.MD lists semaglutide at $212 per month on the twelve-month option and says that option is billed every 48 weeks. Its one-month plan is $249 every four weeks, with a current $50 first-order code.

The tell: “with annual plan,” “prepaid” or a billing period longer than the displayed monthly number.

The offer that already ended—with receipts

This is one of the strongest finds in the audit because the company published the evidence itself.

Embody's current Terms list its retired first-month discount beside its current program. The old program is labeled “NO LONGER ACTIVE.”

The same document labels this as the main active program, updated July 1, 2026:

The cash charges for the prepaid options are the monthly average multiplied by the term: $228 or $378 for three months, $438 or $738 for six months, and $828 or $1,428 for twelve months.

Read that again. A company ran a $99-to-$299 intro structure, retired it, and replaced it with a lower current flat price. Its own Terms are the receipt.

Several old review pages—including older pages on our own site—may still quote Embody's retired $99 first month. Those pages must be corrected. If you see $99 described as the current Embody intro price, the page is stale.

Offers with a real expiration date

Real deadlines only. No fake countdown timer.

Those are the dated offers we could verify in current primary terms. If a deadline passes, treat the row as expired until the official page confirms a replacement.

Why does every website list a different first-month price for the same program?

Answer: Sometimes the landing page, product page and checkout describe the same deal in different units. One page shows a discounted monthly average. Another shows the true one-month plan. A third shows the full prepaid charge.

Enhance.MD is the cleanest current example because both numbers are on its own official pages:

• The homepage says compounded semaglutide starts at $112 for the first month, then $212 per month.
• The semaglutide product page says the one-month plan is $249 every four weeks, with $50 off the first one-month order. That makes the published one-month path $199 today, then $249.
• The same product page says the $212 monthly figure belongs to a twelve-month option billed every 48 weeks, with $100 off the first order.

The $112 headline is the $212 long-plan monthly average minus a one-time $100 coupon. It is not the cash charge on the one-month plan.

Embody shows another version. Its current Terms use $299 as the old reference price while the active plan is $79. A shopper who sees only “save $220” may think $79 is a temporary first-month rate even though the current Terms describe it as the active flat program.

What to do in one sentence: screenshot the final checkout total, billing period, renewal amount and cancellation rule before confirming.

That is not cynicism. It is a thirty-second habit that can save hundreds of dollars.

How we handle it here: we separate the provider's headline from the actual transaction. When a public page does not show the next charge, we print “not publicly fixed” instead of importing an old number from another review site.

Do I need insurance to get a first month discount?

Answer: No. Most offers on this page are cash-pay. But commercial insurance, a manufacturer savings offer or the Medicare GLP-1 Bridge may lower the medicine cost for someone who qualifies. None is guaranteed.

We would rather lose a click than have you skip a coverage path that could save real money.

Check coverage before you pay cash

Ro offers a free commercial-insurance check for Ozempic, Wegovy and Zepbound and says its team handles the coverage paperwork for eligible routes. Prior authorization is when the plan asks the prescriber to show that you meet its rules before it pays. Our GLP-1 prior-authorization provider guide compares the providers that publish help with that work.

Manufacturer savings programs can reduce an eligible commercially insured patient's payment to as little as $25, subject to the program's maximum savings, diagnosis, prescription, coverage and other terms. That is not a promise that every commercially insured patient pays $25.

Government-insurance beneficiaries are generally excluded by the manufacturer offer terms. The accurate reason to give the reader is the written eligibility rule—not a blanket claim that a federal law makes every coupon use illegal.

Two minutes, no card, no commitment. This is the step most likely to prevent an avoidable cash payment.

If you have Medicare Part D

The Medicare GLP-1 Bridge launched July 1, 2026. Eligible Part D members can get covered Foundayo tablets, Wegovy injections or tablets, or the Zepbound KwikPen for a $50 monthly medicine copay through December 31, 2027. Prior authorization and the program's eligibility rules apply. A separate clinician or membership fee can still exist.

Start with our Medicare GLP-1 Bridge paperwork guide, not a compounded cash plan.

If you are paying cash

Use the transaction table and the first-three-payment table above. Do not rank a $39 membership-only offer above a $49 medicine-included offer without adding the medicine.

HSA and FSA cards

Some programs say they accept HSA or FSA cards. Card acceptance does not decide whether your expense is tax-qualified. Keep the itemized receipt and ask your plan administrator when the membership, medicine or program bundle is unclear.

Are compounded GLP-1 discounts the same as brand-name savings?

Answer: No. Compounded drugs are not FDA-approved. The FDA does not verify their safety, effectiveness or quality before they are marketed. Wegovy, Zepbound and Foundayo are FDA-approved for weight management. Ozempic and Mounjaro are FDA-approved for type 2 diabetes, not weight management.

This is the most important section on the page, so we will keep it plain.

Compounded means a licensed pharmacy or outsourcing facility prepares a drug under compounding rules for a patient or other permitted use. Compounding can meet a real medical need when an FDA-approved product cannot meet that patient's need. It is not the same as FDA approval, and a compounded drug is not an FDA-approved generic.

FDA-approved means the finished drug went through the FDA review process and has approved prescribing information. Wegovy comes as an injection and a pill for weight management. Zepbound is approved for chronic weight management and certain obesity-related sleep-apnea use. Foundayo was approved April 1, 2026 for long-term weight reduction in eligible adults.

Ozempic and Mounjaro are different: they are FDA-approved for type 2 diabetes. A clinician may make an off-label decision, but a page should not call them FDA-approved weight-loss drugs.

The current shortage rule matters

The FDA determined the tirzepatide injection shortage was resolved in December 2024 and the semaglutide injection shortage was resolved in February 2025. The broad shortage-era enforcement windows ended.

That does not mean every patient-specific compounded prescription is illegal. It means routine copies face tighter rules. Under section 503A, the prescriber may need to document a change that makes a significant difference for an identified patient. Section 503B outsourcing facilities also face limits on products that are essentially copies of approved drugs.

A low cash price does not answer that medical-and-legal question for your prescription. Ask why the compounded version is needed for you.

The FDA's other current concerns

The FDA has warned about:

• compounded products marketed as “generic Wegovy” or “generic Zepbound”;
• claims that a compounded product is the same as, or sourced from, an FDA-approved brand;
• semaglutide sodium or acetate salt forms that are different active ingredients from the semaglutide base used in approved drugs;
• dosing mistakes caused by different vial concentrations, syringe units or unclear instructions;
• marketing claims that make unapproved products look FDA-reviewed.

Language we will not use: “generic Wegovy,” “generic Zepbound,” “the same as the brand,” or “FDA-approved ingredients” as if that makes the finished compounded product approved.

Seven questions for any compounded program

1. Which pharmacy will make my medicine, and what is its address?
2. Is it a state-licensed 503A pharmacy or an FDA-registered 503B outsourcing facility?
3. What exact active ingredient, formulation and concentration will be on my label?
4. For semaglutide, is it semaglutide base—not semaglutide sodium or acetate?
5. What syringe units equal my prescribed dose, and will I get written instructions?
6. Why does the prescriber believe this compounded version meets my individual need now that the shortage is resolved?
7. What is refunded if the clinician declines to prescribe or the pharmacy never dispenses?

Embody publicly names four partner pharmacies: RedRock Pharmacy in Utah, Health Warehouse in Kentucky, Precision Compounding Pharmacy in New York and Triad Rx in Alabama. Naming the pharmacy before payment is better than hiding it until the box arrives.

A verified limitation: Triad Rx and OpenLoop Health, the clinical network Embody names, were named as defendants in a federal class-action complaint filed November 20, 2025, about compounded oral tirzepatide sold through other storefronts. The complaint contains allegations, not court findings. It does not establish that Embody's injectable products are defective. A fair page must say all three things.

Which first month discount fits my situation?

Answer: The right choice depends on the product category, your coverage, how the provider charges before approval, the care format and whether you can carry the next payment. First-month price is not the first question.

Find yourself in this table.

Who should skip all of this

Let's be blunt, because it saves money.

If you want an FDA-approved self-pay weight-management medicine for under $100 in the first month, we did not verify one. The lowest medicine-only starting price here is $149. A telehealth fee can push the total higher. The $50 Medicare Bridge is a separate covered route for eligible Part D members.

If the next $299, $399, $537 or $597 charge would force you to quit, do not choose that renewal structure. Pick a payment you can carry, and talk with the prescribing clinician before stopping or changing treatment.

If you think a low first payment means low commitment, read the cancel-by register again. A $25 offer tied to twelve months can be a bigger commitment than a $79 month-to-month plan.

Two doors, pick yours.

Still not sure? Keep reading—the safety checks below are the ones we would want a family member to run.

Is the cheapest one safe? How we check a program

Answer: Price cannot prove safety. Four checks can still expose a lot: the named pharmacy and exact formulation, the FDA status of the finished product, any published FDA warning letter and the provider's own payment/refund terms.

Check 1 — Who makes the medicine?

A provider should be able to name the dispensing pharmacy before you pay or explain when that name becomes available. Confirm the pharmacy with the relevant state board or the FDA's outsourcing-facility list when applicable.

Check 2 — What is the product's FDA status?

Do not let “made in an FDA-regulated facility,” “uses an FDA-approved ingredient” or “doctor prescribed” turn into “FDA-approved medicine” in your head. The finished compounded product is still not FDA-approved.

Check 3 — Is there a published FDA warning letter?

An FDA warning letter is a formal agency notice describing alleged violations and asking for correction. The two letters below concern false or misleading marketing and misbranding claims about compounded products. They are not findings that every dose dispensed through the company was fake or poisonous.

Check 4 — What do the terms say when the sale goes wrong?

Read the charge timing, medical-disqualification refund, renewal cadence, cancellation deadline, prepaid refund rule and dispute clause. A beautiful landing page cannot override the Terms you accept.

The two programs we will not link to

We keep their pricing in the dataset because leaving them out would make the comparison incomplete. We do not send readers to them.

MEDVi. Its official page advertises compounded injections starting at $179. The FDA issued MEDVi a warning letter dated February 20, 2026 after reviewing claims about compounded semaglutide and tirzepatide. The letter describes false or misleading statements about the source and FDA status of compounded products. MEDVi's current public page does not give us one fixed refill amount, so the old $299 figure is not presented as verified here.

Direct Meds. Its official page currently says compounded tirzepatide is $199 for the first month and $399 after, with the same price at every dose. The FDA issued Direct Meds a warning letter dated September 9, 2025 concerning claims that made compounded products appear the same as or equivalent to FDA-approved drugs.

Neither letter says every patient received an unsafe product. Both letters matter because a reader deciding between an approved brand and an unapproved compound needs clean labeling and marketing.

Our standing rule: we do not place a signup link to a program while an FDA warning letter about how it markets these compounded medicines remains a material unresolved trust signal in our review. That rule costs revenue. We would rather have the rule.

What we verified about the paths we do recommend

Embody — Publishes current flat prices and names four partner pharmacies. Medical care is provided through OpenLoop Health. Known limits: checkout before final clinician review; public refund and cancellation language that does not fully agree; binding arbitration with a 30-day opt-out; compounded products are not FDA-approved; and the oral-tirzepatide complaint described above.

Ro — Publishes membership tiers, eligibility refund and dose-by-dose cash prices on one page. Its weight-loss program currently centers on FDA-approved medicines. Medicine and membership are separate, and the cheapest ongoing membership requires prepayment.

Yucca Health — Publishes an authorization-hold rule and says it charges only if prescribed. It also publishes starting plan prices and UPS 2-Day shipping. Its products on the cited weight-loss route are compounded, and exact dose/renewal detail is not all visible before intake.

Sesame — Publishes live video visits with a provider the patient chooses, medication routes with or without insurance and a separate care membership. It is a fit recommendation for people who value face-to-face care, not the winner of the cheapest-first-charge table.

What we do not use as proof

We include real, attributable quotes only, and we never use a customer quote to prove that a medicine is safe, that a person will lose a set amount of weight or that a billing policy applies to every customer. We did not publish a testimonial block because no quote was needed to support the billing facts on this page.

For billing, the contract, checkout and written policy beat a review. Reviews can tell us what to investigate. They do not replace the source.

How we verified all of this

Answer: Weight Loss Provider Guide is an independent comparison resource. For this audit, we read official pricing pages, product pages, terms, cancellation/refund policies, manufacturer cash-pay pages, FDA materials and Medicare rules on August 11, 2026. We separated provider-stated numbers from our own arithmetic.

Our source order

1. The provider's Terms and Conditions
2. The provider's checkout or product-plan page
3. The provider's cancellation and refund policy
4. The provider's general pricing page
5. FDA, CMS and drug-manufacturer sources
6. Written provider support confirmation
7. Third-party review platforms—for service patterns only
8. Forums—for the words people use to describe a problem, never as proof of price, safety or law

What counts as verified here

A provider-stated number is verified when it appears on an official current page and we record the date. A calculated number is verified when every input is official and the arithmetic is shown. A number is not verified merely because several review sites repeat it.

That is why MEDVi's $179 start remains and its old $299 refill does not. It is why Enhance.MD's $112 headline remains in the “advertised hook” column but not in the “card charge on the one-month path” column.

How we rank

In this order:

1. Product category and fit for the reader's stated goal
2. Billing clarity and what is actually charged
3. FDA-approved versus compounded route
4. Ongoing affordability, not only the first payment
5. Charge-before-approval and refund terms
6. Cancellation and commitment
7. Regulatory and trust signals
8. Care format and insurance help

Commercial relationships are used only as a tiebreaker between paths we would already recommend equally. A provider cannot pay us to remove a verified drawback.

Original data on this page

This page adds five things that do not come from copying one provider page:

• a transaction table that separates the ad number from the card charge;
• first-three-payment cash math across different billing periods;
• a provider-stated-versus-transaction table;
• a public Billing Clarity Score with the questions shown;
• the retired Embody intro table beside its active flat-price table.

Corrections

Prices can change without notice. If a number is wrong, send the official provider page, checkout screenshot and date. We will check it and log the change.

Update log

Primary sources checked

• Embody Terms and Conditions
• Embody cancellation and refund policy
• Noom 2026 pricing
• Ro weight-loss pricing
• Hims Weight Loss membership and Wegovy pill route
• Hims Terms and Conditions
• Hers weight-loss pricing
• Yucca Health: how it works and pricing
• MEDVi official starting-price and cancellation pages (checked August 11, 2026; no outbound signup link)
• Direct Meds official pricing page (checked August 11, 2026; no outbound signup link)
• Eden semaglutide pricing
• Enhance.MD semaglutide product pricing
• Enhance.MD tirzepatide product pricing
• Alloy Weight Care pricing
• Helimeds compounded GLP-1 pricing
• WeightWatchers plans and offer terms
• PlushCare GLP-1 pricing
• Mochi weight-loss pricing
• NovoCare Pharmacy
• LillyDirect Zepbound
• LillyDirect Foundayo
• FDA: Compounding and the FDA—Questions and Answers
• FDA: GLP-1 compounding policy after shortages
• FDA warning letter to MEDVi
• FDA warning letter to Direct Meds
• Federal class-action complaint naming OpenLoop Health and Triad Rx, filed November 20, 2025
• Medicare GLP-1 Bridge coverage

Frequently asked questions

Which GLP-1 provider has the cheapest first month?

WeightWatchers Med+ has the lowest membership-only intro at $25, but medicine is extra and the offer is tied to a 12-month plan. Noom has the lowest verified medicine-included start at $49 for four weeks of low-dose compounded semaglutide, before tax. Its first renewal is $537 for twelve weeks. Embody has the lowest complete three-monthly-payment total we calculated at $237.

Which GLP-1 providers start at $39?

Ro, Hims, Hers, Eden and Mochi publish a $39 first-month membership or care fee on the routes reviewed. The medicine is separate for all five. At Ro or Hims/Hers, a lowest-dose $149 pill makes the first combined total $188.

What is the cheapest FDA-approved GLP-1 first month without insurance?

The lowest verified medicine-only starting price in this audit is $149 for the lowest dose of the Wegovy pill or Foundayo. A telehealth or clinician fee may be added. Through Ro's month-to-month route, the lowest combined pill path starts at $188.

Does the first month discount include the medicine?

Sometimes. Nine of the 16 provider/manufacturer-route families in our count include the medicine in the headline price or are the medicine price itself. Seven exclude it. Read the “What leaves your card now” column, not only the ad hook.

Why is the next Noom charge $537 or $597?

The first low-dose supply is four weeks. The renewal is twelve weeks. Low-dose semaglutide renews at $537, or $179 per four weeks. Low-dose tirzepatide renews at $597, or $199 per four weeks. Taxes can add to both.

Is $99 a month always billed monthly?

No. Helimeds advertises EasyStart at $99 per month but says the twelve-week plan is paid upfront, is not a subscription and has no automatic renewal. The displayed plan math is $297 once.

Can I cancel before the second charge?

Usually, if the request arrives before the written deadline. Embody's strictest published rule is five days before the end of the prescription period. MEDVi requires 72 hours before the billing date. Hims/Hers requires two days before each renewal. Save written confirmation.

Will I get a refund if I am not prescribed the medicine?

It depends. Ro says the $39 is refunded if you are not eligible. Yucca says it only completes the charge if prescribed. MEDVi says it gives a full refund for medical disqualification. Embody's refund page and Terms do not use the same wording, so get the promise in writing before paying.

Does the price go up when my dose goes up?

It can. Ro, NovoCare, LillyDirect and Mochi publish dose-based or dose-variable pricing. Embody's current plan says the price stays the same for the same medicine and plan. Direct Meds says the $399 ongoing price is the same at every dose. Membership fees can rise even when the medicine price does not.

Are first-month discounts only for new patients?

Most are. Noom, Alloy, Mochi, Ro/Hims/Hers, WeightWatchers and manufacturer starter offers use new-customer, first-month, first-fill or signup-date terms. Do not assume canceling and returning will restore the intro price unless the written terms say so.

Can I combine a first-month discount with insurance?

Usually the cash offer and insurance route are separate. Check the exact terms. A manufacturer savings card may work with eligible commercial coverage. Cash-pay manufacturer prices generally do not stack with insurance reimbursement.

Can I use an HSA or FSA card?

Some programs accept the card. Whether the expense is qualified depends on the item, your plan and your tax situation. Keep an itemized receipt and ask the plan administrator.

Are compounded GLP-1 medicines FDA-approved?

No. The FDA does not verify a compounded drug's safety, effectiveness or quality before marketing. A compounded product is not an FDA-approved generic, even when it contains an active ingredient also used in an approved medicine.

Is Ozempic FDA-approved for weight loss?

No. Ozempic is FDA-approved for type 2 diabetes and related labeled uses. Wegovy is the semaglutide brand approved for weight management. Mounjaro is approved for type 2 diabetes; Zepbound is the tirzepatide brand approved for weight management.

Is a manufacturer savings offer the same as a provider discount?

No. NovoCare and LillyDirect set manufacturer self-pay or savings terms. Several telehealth companies can route an eligible prescription into the same price. Compare the telehealth fee, care, refund and cancellation—not only the repeated medicine price.

How often do you check these prices?

The full page was checked on August 11, 2026. A new “last verified” date should appear only after the provider pages and terms are rechecked. Time-limited rows must be removed or updated as soon as their published deadlines pass.

One last thing

If you take nothing else from this page, take this: the discount is not the deal. The second charge is the deal.

You already know you want to try this. You've done the reading. You've probably been thinking about it for months. The only thing standing between you and starting is not knowing what you're really signing up for — and now you do.

Screenshot your checkout. Write down the next charge. Set your cancel-by reminder. Then go.

Take our free 60-second matching quiz No signup is required to see the result.

Weight Loss Provider Guide is an independent comparison resource for GLP-1 telehealth providers. We are not a medical provider, pharmacy or telehealth platform. This page is general information, not medical advice. A licensed clinician must decide whether any medicine is appropriate. Prices, availability, terms and manufacturer offers can change without notice. Confirm the final amount, billing period, prescription status and cancellation rule before paying.

Wegovy and Ozempic are trademarks of Novo Nordisk A/S. Mounjaro, Zepbound, KwikPen and Foundayo are trademarks of Eli Lilly and Company. Weight Loss Provider Guide is independent and is not affiliated with or endorsed by either company.